Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 51
1993 62
1994 67
1995 77
1996 1
1997 12
1998 10
1999 92
2000 92
2001 100
2002 101
2003 168
2004 170
2005 227
2006 452
2007 369
2008 238
2009 319
2010 280
2011 263
2012 274
2013 260
2014 285
2015 316
2016 271
2017 299
2018 268
2019 297
2020 462
2021 337
2022 305
2023 399
2024 120

Text availability

Article attribute

Article type

Publication date

Search Results

6,703 results

Results by year

Filters applied: . Clear all
Page 1
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A, Fischerová D, Jahnn-Kuch D, Joly F, Kohler C, Lax S, Lorusso D, Mahantshetty U, Mathevet P, Naik R, Nout RA, Oaknin A, Peccatori F, Persson J, Querleu D, Bernabé SR, Schmid MP, Stepanyan A, Svintsitskyi V, Tamussino K, Zapardiel I, Lindegaard J. Cibula D, et al. Int J Gynecol Cancer. 2023 May 1;33(5):649-666. doi: 10.1136/ijgc-2023-004429. Int J Gynecol Cancer. 2023. PMID: 37127326 Free PMC article.
Updates on cervical cancer prevention.
Viveros-Carreño D, Fernandes A, Pareja R. Viveros-Carreño D, et al. Int J Gynecol Cancer. 2023 Mar 6;33(3):394-402. doi: 10.1136/ijgc-2022-003703. Int J Gynecol Cancer. 2023. PMID: 36878567 Review.
Endometrial carcinosarcoma.
Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Caruso G, Enomoto T, Takehara K, Denys H, Lorusso D, Coleman R, Vaughan MM, Takano M, Provencher DM, Sagae S, Wimberger P, Póka R, Segev Y, Kim SI, Kim JW, Candido Dos Reis FJ, Ramirez PT, Mariani A, Leitao M, Makker V, Abu-Rustum NR, Vergote I, Zannoni G, Tan D, McCormack M, Paolini B, Bini M, Raspagliesi F, Benedetti Panici P, Di Donato V, Muzii L, Colombo N, Pignata S, Scambia G, Monk BJ. Bogani G, et al. Int J Gynecol Cancer. 2023 Feb 6;33(2):147-174. doi: 10.1136/ijgc-2022-004073. Int J Gynecol Cancer. 2023. PMID: 36585027 Review.
Immunotherapy in endometrial cancer.
Mahdi H, Chelariu-Raicu A, Slomovitz BM. Mahdi H, et al. Int J Gynecol Cancer. 2023 Mar 6;33(3):351-357. doi: 10.1136/ijgc-2022-003675. Int J Gynecol Cancer. 2023. PMID: 36878570 Review.
Avascular spaces in radical hysterectomy.
Zapardiel I, Ceccaroni M, Minig L, Halaska MJ, Fujii S. Zapardiel I, et al. Int J Gynecol Cancer. 2023 Feb 6;33(2):285-292. doi: 10.1136/ijgc-2022-004071. Int J Gynecol Cancer. 2023. PMID: 36581489 Review.
New therapies for clear cell ovarian carcinoma.
Stewart J, Cunningham N, Banerjee S. Stewart J, et al. Int J Gynecol Cancer. 2023 Mar 6;33(3):385-393. doi: 10.1136/ijgc-2022-003704. Int J Gynecol Cancer. 2023. PMID: 36878571 Review.
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.
Kesic V, Carcopino X, Preti M, Vieira-Baptista P, Bevilacqua F, Bornstein J, Chargari C, Cruickshank M, Erzeneoglu E, Gallio N, Gultekin M, Heller D, Joura E, Kyrgiou M, Madić T, Planchamp F, Regauer S, Reich O, Esat Temiz B, Woelber L, Zodzika J, Stockdale C. Kesic V, et al. Int J Gynecol Cancer. 2023 Apr 3;33(4):446-461. doi: 10.1136/ijgc-2022-004213. Int J Gynecol Cancer. 2023. PMID: 36958755 Free PMC article. Review.
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.
Oonk MHM, Planchamp F, Baldwin P, Mahner S, Mirza MR, Fischerová D, Creutzberg CL, Guillot E, Garganese G, Lax S, Redondo A, Sturdza A, Taylor A, Ulrikh E, Vandecaveye V, van der Zee A, Wölber L, Zach D, Zannoni GF, Zapardiel I. Oonk MHM, et al. Int J Gynecol Cancer. 2023 Jul 3;33(7):1023-1043. doi: 10.1136/ijgc-2023-004486. Int J Gynecol Cancer. 2023. PMID: 37369376 Free PMC article.
FIGO 2023 endometrial cancer staging: too much, too soon?
McCluggage WG, Bosse T, Gilks CB, Howitt BE, McAlpine JN, Nucci MR, Rabban JT, Singh N, Talia KL, Parra-Herran C. McCluggage WG, et al. Int J Gynecol Cancer. 2023 Nov 7:ijgc-2023-004981. doi: 10.1136/ijgc-2023-004981. Online ahead of print. Int J Gynecol Cancer. 2023. PMID: 37935523 Review.
Biomarker-driven therapy in endometrial cancer.
Karpel H, Slomovitz B, Coleman RL, Pothuri B. Karpel H, et al. Int J Gynecol Cancer. 2023 Mar 6;33(3):343-350. doi: 10.1136/ijgc-2022-003676. Int J Gynecol Cancer. 2023. PMID: 36878569 Review.
6,703 results